產品編號 | bs-41432P |
英文名稱 | Recombinant SARS-Cov-2 Papain-Like Protease, His |
中文名稱 | 重組SARS-CoV-2 (2019-nCoV) Papain-Like Protease |
別 名 | Papain-like Protease; PLpro; PL-PRO; pp1a; Replicase polyprotein 1a; Recombinant SARS-Cov-2 Papain-Like Protease, His 新冠病毒PLpro; 新冠PLpro; SARS-CoV-2 PLpro; |
理論分子量 | 35.8kDa |
檢測分子量 | 26 |
性 狀 | Liquid |
濃 度 | >0.5 mg/ml |
物 種 | SARS-Cov-2 |
序 列 | 1564-1880/7096 |
純 度 | >90% as determined by SDS-PAGE |
純化方法 | AC |
內毒素 | Not analyzed |
表達系統 | E.coli |
活性 | Not tested |
標簽 | His |
保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產品介紹 |
Replication of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) requires proteolytic processing of the replicase polyprotein by two viral cysteine proteases, a chymotrypsin-like protease (3CLpro) and a papain-like protease (PLpro). These proteases are important targets for development of antiviral drugs that would inhibit viral replication and reduce mortality associated with outbreaks of SARS-CoV. PLpro is a cysteine protease located within the non-structural protein 3 (NS3) section of the viral polypeptide. PLPro activity is required to process the viral polyprotein into functional, mature subunits; specifically, PLPro cleaves a site at the amino-terminus of the viral replicase region. In addition to its role in viral protein maturation, PLPro possesses a deubiquitinating and deISGylating activity. In vivo, this protease antagonizes innate immunity by inhibiting IRF3-induced production of type I interferons. SWISS: P0DTD1 Gene ID: 43740578 |
1、抗體溶解方法 | |
2、抗體修復方式 | |
3、常用試劑的配制 | |
4、免疫組化操作步驟 | |
5、免疫組化問題解答 | |
6、Western Blotting 操作步驟 | |
7、Western Blotting 問題解答 | |
8、關于肽鏈的設計 | |
9、多肽的溶解與保存 | |
10、酶標抗體效價測定程序 | |